Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Research Advances in the Treatment of Urinary System Diseases with “Zhibian”(BL54)-toward-“Shuidao” (ST28)
View through CrossRef
The needling technique of directionally penetrating from “Zhibian” (BL54)-toward-“Shuidao” (ST28) is a characteristic long-needle deep-penetration method in Traditional Chinese Medicine (TCM), originating from *Huangdi Neijing* (Yellow Emperor’s Inner Canon). It demonstrates significant efficacy and broad application potential in treating genitourinary disorders. This paper systematically reviews the technique’s historical origins, anatomical foundations, and standardized protocols. Clinical evidence supporting its therapeutic advantages—such as bidirectional bladder function modulation, alleviation of prostatic diseases, and management of stress urinary incontinence—is critically analyzed. Mechanistically, the role of apoptotic factor regulation and neuroendocrine network modulation is explored. Current research has established a standardized technical framework. Future studies should expand evidence-based investigations into its application for perimenopausal syndrome and ovarian hyporesponse.
Title: Research Advances in the Treatment of Urinary System Diseases with “Zhibian”(BL54)-toward-“Shuidao” (ST28)
Description:
The needling technique of directionally penetrating from “Zhibian” (BL54)-toward-“Shuidao” (ST28) is a characteristic long-needle deep-penetration method in Traditional Chinese Medicine (TCM), originating from *Huangdi Neijing* (Yellow Emperor’s Inner Canon).
It demonstrates significant efficacy and broad application potential in treating genitourinary disorders.
This paper systematically reviews the technique’s historical origins, anatomical foundations, and standardized protocols.
Clinical evidence supporting its therapeutic advantages—such as bidirectional bladder function modulation, alleviation of prostatic diseases, and management of stress urinary incontinence—is critically analyzed.
Mechanistically, the role of apoptotic factor regulation and neuroendocrine network modulation is explored.
Current research has established a standardized technical framework.
Future studies should expand evidence-based investigations into its application for perimenopausal syndrome and ovarian hyporesponse.
Related Results
Clinical study on improving the function of female bladder in controlling urine by acupuncture Zhibian (BL54) under ultrasound guidance
Clinical study on improving the function of female bladder in controlling urine by acupuncture Zhibian (BL54) under ultrasound guidance
Abstract
Objective
To observe the effect of acupuncture Zhibian (BL54) on the function of the bladder in controlling urine in women under ultrasound...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Effect of an Acupuncture Technique of Penetrating through Zhibian (BL54) to Shuidao (ST28) with Long Needle for Pain Relief in Patients with Primary Dysmenorrhea: A Randomized Controlled Trial
Effect of an Acupuncture Technique of Penetrating through Zhibian (BL54) to Shuidao (ST28) with Long Needle for Pain Relief in Patients with Primary Dysmenorrhea: A Randomized Controlled Trial
Background. Primary dysmenorrhea (PD) is the commonest gynecological disorder in young women of reproductive age, and there is not always satisfactory relief of pain treated by com...
Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms in Men
Phosphodiesterase-5 Inhibitors for Lower Urinary Tract Symptoms in Men
Objective:
To review the efficacy of phosphodiesterase-5 (PDE-5) inhibitors for the treatment of lower urinary tract symptoms in men.
...
Prevalence, Risk Factors and Costs of Female Urinary Incontinence: A Multicentre Cross‐Sectional Study
Prevalence, Risk Factors and Costs of Female Urinary Incontinence: A Multicentre Cross‐Sectional Study
ABSTRACT
What is the prevalence of urinary incontinence and its main subtypes among middle‐aged women in Northern Italy? How do urinary incon...
Role of Urinary Apolipoprotein A1 level in Predicting Development of Cancer of Urinary Bladder
Role of Urinary Apolipoprotein A1 level in Predicting Development of Cancer of Urinary Bladder
Background: Urinary bladder cancer is the tenth most common malignant condition globally. Now incidence and prevalence of bladder cancer is gradually increasing. Urinary biomarker ...